Shay Capital LLC - Q2 2022 holdings

$498 Million is the total value of Shay Capital LLC's 423 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
PRVA  PRIVIA HEALTH GROUP INC$728,000
+9.0%
25,0000.0%0.15%
+69.8%
ALHC  ALIGNMENT HEALTHCARE INC$571,000
+1.6%
50,0000.0%0.12%
+59.7%
SPLK  SPLUNK INC$531,000
-40.5%
6,0000.0%0.11%
-6.1%
RMGCU  RMG ACQUISITION CORP IIIunit 02/08/2026$296,000
-0.3%
30,0000.0%0.06%
+55.3%
VNCE  VINCE HLDG CORP$263,000
-3.7%
33,5250.0%0.05%
+51.4%
DHHCU  DIAMONDHEAD HOLDINGS CORPunit 01/21/2026$254,000
-0.8%
25,9000.0%0.05%
+54.5%
TTSH  TILE SHOP HLDGS INC$241,000
-53.1%
78,5180.0%0.05%
-27.3%
CWH  CAMPING WORLD HLDGS INCcall$216,000
-22.9%
10,0000.0%0.04%
+19.4%
PDOTU  PERIDOT ACQUISITION CORP IIunit 99/99/9999$176,000
-0.6%
18,0020.0%0.04%
+52.2%
TCS  CONTAINER STORE GROUP INC$122,000
-23.3%
19,5190.0%0.02%
+25.0%
CLIMU  CLIMATE REAL IMPACT SLUTINSunit 99/99/9999$108,0000.0%10,9390.0%0.02%
+57.1%
PCTTW  PURECYCLE TECHNOLOGIES INC*w exp 03/17/202$106,000
-7.8%
40,0000.0%0.02%
+40.0%
 TG VENTURE ACQUISITION CORPunit 08/15/2028$99,000
-1.0%
10,0000.0%0.02%
+53.8%
CLIM  CLIMATE REAL IMPACT SLUTINS$98,0000.0%10,0000.0%0.02%
+53.8%
ATER  ATERIAN INC$65,000
-11.0%
30,0000.0%0.01%
+44.4%
INFN  INFINERA CORP$54,000
-37.9%
10,0000.0%0.01%0.0%
AGTC  APPLIED GENETIC TECHNOLOGIES$39,000
-27.8%
50,0000.0%0.01%
+14.3%
RNAZ  TRANSCODE THERAPEUTICS INC$19,000
-55.8%
15,0600.0%0.00%
-33.3%
DMAC  DIAMEDICA THERAPEUTICS INC$20,000
-20.0%
10,0000.0%0.00%
+33.3%
 GENERATION INCOME PPTYS INC*w exp 09/03/202$12,000
-7.7%
20,9030.0%0.00%0.0%
 HARBOR CUSTOM DEVELOPMENT IN*w exp 10/04/202$9,0000.0%25,0000.0%0.00%
+100.0%
ABEO  ABEONA THERAPEUTICS INC$10,000
-37.5%
50,0000.0%0.00%0.0%
 AMERICAN REBEL HOLDINGS INC*w exp 01/20/202$4,000
-55.6%
25,0000.0%0.00%0.0%
HCDIW  HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202$7,000
-30.0%
34,5000.0%0.00%0.0%
KRBP  KIROMIC BIOPHARMA INC$7,000
-53.3%
17,3000.0%0.00%
-50.0%
 SEQLL INC*w exp 08/31/202$3,000
-62.5%
20,0000.0%0.00%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TR12Q3 202325.6%
INVESCO QQQ TR12Q3 20237.6%
REKOR SYSTEMS INC12Q3 20232.0%
AMAZON COM INC12Q3 20231.8%
ASSURANT INC12Q3 20231.0%
INTL GNRL INSURANCE HLDNGS L12Q3 20230.6%
ADVANCED MICRO DEVICES INC12Q3 20230.3%
SPDR S&P 500 ETF TR11Q3 202310.2%
AMAZON COM INC11Q3 20232.9%
ISHARES TR11Q3 20231.4%

View Shay Capital LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Shay Capital LLC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PharmaCyte Biotech, Inc.Sold outFebruary 14, 202300.0%
Exela Technologies, Inc.February 13, 20238,250,0006.8%
HyreCar Inc.February 10, 2022957,5464.4%

View Shay Capital LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
SC 13G2023-09-29
13F-HR2023-08-14
SC 13G2023-08-03
13F-HR2023-05-15

View Shay Capital LLC's complete filings history.

Compare quarters

Export Shay Capital LLC's holdings